Chemoinformaics analysis of CAFFEIC-ACID-ESTER
| Molecular Weight | 194.186 | nRot | 2 |
| Heavy Atom Molecular Weight | 184.106 | nRig | 8 |
| Exact Molecular Weight | 194.058 | nRing | 1 |
| Solubility: LogS | -1.27 | nHRing | 0 |
| Solubility: LogP | 1.957 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 26.5759 |
| nHD | 2 | BPOL | 12.6361 |
| QED | 0.423 |
| Synth | 2.065 |
| Natural Product Likeliness | 1.131 |
| NR-PPAR-gamma | 0.375 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.077 |
| HIA | 0.02 |
| CACO-2 | -4.631 |
| MDCK | 0.0000197 |
| BBB | 0.185 |
| PPB | 0.858366 |
| VDSS | 0.39 |
| FU | 0.104198 |
| CYP1A2-inh | 0.899 |
| CYP1A2-sub | 0.696 |
| CYP2c19-inh | 0.252 |
| CYP2c19-sub | 0.078 |
| CYP2c9-inh | 0.436 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.164 |
| CYP2d6-sub | 0.732 |
| CYP3a4-inh | 0.292 |
| CYP3a4-sub | 0.227 |
| CL | 15.624 |
| T12 | 0.93 |
| hERG | 0.034 |
| Ames | 0.375 |
| ROA | 0.801 |
| SkinSen | 0.94 |
| Carcinogencity | 0.392 |
| EI | 0.461 |
| Respiratory | 0.448 |
| NR-Aromatase | 0.195 |
| Antiviral | No |
| Prediction | 0.870962 |